Fact Sheet: Optimizing preconception health

Screen Shot 2018-05-06 at 8.05.47 PM

optimizing-preconception-health-fact-sheet-eng

Information for health care providers

  • Encourage women considering pregnancy to schedule a visit to discuss preconception health and the optimization of maternal and fetal outcomes.
  • Take advantage of episodic visits to identify health risks, offer related interventions and encourage positive health behaviours prior to conception.
  • Encourage all women and men of reproductive age to develop a reproductive-life plan, whether they intend to have children or not.
  • Recommend a daily multivitamin containing 400 mcg (0.4 mg) of folic acid for all women of reproductive age who could become pregnant, and discuss risk factors that may warrant a higher dose.
  • Ensure that immunizations are complete and up-to-date, using immunization history or serological testing for routinely recommended adult vaccines and those for which pregnancy requires specific screening.
  • Review all medications for their potential teratogenicity and counsel women about the potential impact on a pregnancy, regardless of their plans to conceive.
  • Discuss the effects of alcohol in pregnancy and encourage abstinence leading up to and during pregnancy.
  • Promote smoking cessation. Prepregnancy is the ideal time to stop smoking in order to prevent adverse perinatal outcomes associated with maternal smoking.
  • Encourage progress towards healthier weights in women who are underweight, overweight or obese. Adverse perinatal and maternal outcomes can be reduced with appropriate preconception weight gain or loss.
  • Screen for elevated sexually transmitted infection (STI) risk factors. Identifying an infection before conception allows for timely treatment and prevention of transmission during pregnancy and birth.
  • Optimize chronic medical conditions prior to conception to improve perinatal and maternal outcomes.
  • Encourage 18 to 24 month intervals between completed pregnancies. Both shorter and longer IPIs have been associated with an increased risk of adverse maternal and newborn outcomes.

Leave a Reply